R. Todd Joyce has been named senior vice president and chief financial officer of Watson Pharmaceuticals, effective immediately. Mr. Joyce succeeds Mark W. Durand, who left the company for personal reasons. Mr. Joyce has served as acting principal financial officer since July 27, 2009, when Mr. Durand took a leave of absence. “I, the Board of Directors and the senior management team wish to thank Mark for his service to the Company. We appreciate this was a difficult decision for him, a...